➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Baxter
AstraZeneca
Mallinckrodt
Harvard Business School
Express Scripts

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Evogliptin


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Evogliptin?

Evogliptin is an investigational drug.

There have been 21 clinical trials for Evogliptin. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2021.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Liver Diseases. The leading clinical trial sponsors are Dong-A ST Co., Ltd., REDNVIA, and Samsung Medical Center.

There are forty-six US patents protecting this investigational drug and five hundred and ninety-seven international patents.

Recent Clinical Trials for Evogliptin
TitleSponsorPhase
A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and DapagliflozinDong-A ST Co., Ltd.Phase 4
A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and DapagliflozinKyung Hee University Hospital at GangdongPhase 4
A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mgDong-A ST Co., Ltd.Phase 4

See all Evogliptin clinical trials

Clinical Trial Summary for Evogliptin

Top disease conditions for Evogliptin
Top clinical trial sponsors for Evogliptin

See all Evogliptin clinical trials

US Patents for Evogliptin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Evogliptin ⤷  Try it Free Antidiabetic tricyclic compounds Merck Sharp & Dohme (Rahway, NJ) ⤷  Try it Free
Evogliptin ⤷  Try it Free [5,6]--fused bicyclic antidiabetic compounds Merck Sharp & Dohme Corp. (Rahway, NJ) ⤷  Try it Free
Evogliptin ⤷  Try it Free [7,6]-fused bicyclic antidiabetic compounds Merck Sharp & Dohme Corp. (Rahway, NJ) ⤷  Try it Free
Evogliptin ⤷  Try it Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Try it Free
Evogliptin ⤷  Try it Free Composition containing a DPP-IV inhibitor for preventing or treating renal diseases DONG-A ST Co., Ltd (Seoul, KR) ⤷  Try it Free
Evogliptin ⤷  Try it Free Functionalized Exendin-4 derivatives SANOFI (Paris, FR) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Evogliptin

Drugname Country Document Number Estimated Expiration Related US Patent
Evogliptin Australia AU2015263620 2034-05-22 ⤷  Try it Free
Evogliptin Canada CA2947781 2034-05-22 ⤷  Try it Free
Evogliptin China CN106458913 2034-05-22 ⤷  Try it Free
Evogliptin European Patent Office EP3145915 2034-05-22 ⤷  Try it Free
Evogliptin Japan JP2017516771 2034-05-22 ⤷  Try it Free
Evogliptin South Korea KR20170005861 2034-05-22 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Express Scripts
AstraZeneca
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.